CPB Inc., the Honolulu-based parent of Central Pacific Bank. said Thursday that its board has approved the adoption of a shareholder-rights plan.

The rights plan, or poison pill, will kick in if a would-be buyer deemed "adverse" by the board tries to purchase 10% of CPB stock, or if anyone attempts to acquire 15%.

Subscribe Now

Access to authoritative analysis and perspective and our data-driven report series.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.